Related Experiment Video
Updated: Jan 24, 2026

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
Published on: June 24, 2019
Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER Trial
D Clark Files1, Michael A Matthay1, Lorraine B Ware1
1Wake Forest University School of Medicine (D. C. F., K. W. G., and C. M.), Winston-Salem, NC; the University of California, San Francisco (M. A. M. and S. F.), San Francisco, the University of California, Los Angeles (S. Y. C., G. W. H., and K. D. L.), Los Angeles, CA; the Vanderbilt University Medical Center (L. B. W. and W. H. S.), Nashville, TN; the Johns Hopkins Hospital (R. G. B.), Baltimore, MD; the University of Colorado (N. R. A. and A. G.), the Denver Health Medical Center (I. S. D.), Denver, CO; Intermountain Health (S. M. B.), the University of Utah (E. S. H.), Salt Lake City, UT; the Cleveland Clinic (A. D.), Cleveland, the University of Cincinnati (R. D. H.), Cincinnati, OH; the Massachusetts General Hospital (A. S. F., K. H., W. H., P. L., and B. T. T.), Boston; the Baystate Medical Center (M. A. T.), Springfield, MA; the Medical University of South Carolina (A. G.), Charleston, SC; the Oregon Health and Science University (C. L. H. and A. K.), the Maine Medical Center (R. R.), Portland, OR; the Mount Sinai Hospital (A. M.), New York, NY; the Harborview Medical Center (B. R. H. R.), University of Washington, Seattle, WA, the University of Pittsburgh Medical Center (D. M. Y.), Pittsburgh, PA; and the Virginia Commonwealth University (A. A. F.), Richmond, VA.
High-dose intravenous ascorbate did not improve organ support-free days in patients with sepsis and acute respiratory distress syndrome (ARDS). However, ascorbate did reduce inflammatory markers, suggesting potential benefits in sepsis and lung injury.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Infectious Diseases
Background:
- Previous phase 2 trials suggested potential mortality benefits of high-dose intravenous ascorbate in ARDS.
- However, sepsis trials have not demonstrated clinical benefits, necessitating further investigation.
Purpose of the Study:
- To evaluate the efficacy of high-dose intravenous ascorbate in improving outcomes for patients with sepsis who are at risk of or have ARDS.
- To assess the impact of ascorbate on organ support-free days and other clinical and biological endpoints.
Main Methods:
- A phase 2b multicenter randomized placebo-controlled trial involving 79 participants with sepsis and either shock or acute hypoxemic respiratory failure.
- Patients received either ascorbate (50 mg/kg IV every 6 hours for 5 days) or a matching placebo.
- The primary outcome was days alive and free of respiratory, renal, and circulatory organ support by day 28.
Main Results:
- The trial was terminated early due to a published study reporting increased mortality with ascorbate in septic shock.
- No significant difference was observed in days free of organ support between the ascorbate and placebo groups (20.5 vs 19.0 days, P = .528).
- A trend towards reduced 90-day all-cause mortality was noted in the ascorbate group (15% vs 33%, P = .057), and ascorbate significantly reduced soluble tumor necrosis factor receptor 1 levels.
Conclusions:
- High-dose intravenous ascorbate did not improve organ support-free days in patients with sepsis and ARDS.
- No safety concerns were identified in this small study.
- Ascorbate demonstrated a reduction in a key biological marker of inflammation linked to adverse outcomes in sepsis and lung injury.
Related Concept Videos
Phase Diagrams
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Trial and Error and Algorithm
Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
Critical Values

